Stocks in play: BriaCell Therapeutics Corp.

Barchart · 2d ago

Announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, a leading cancer center in Toronto, has joined BriaCell’s ongoing pivotal Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. BriaCell Therapeutics Corp. shares T.BCT are trading down $0.12 at $5.40.